Home

SAYPHA FILLER (1x1ml) / EX PRINCESS FILLER (1x1ml) CROMA

New

NEW BOX.

FiLLER Universal Treatments.

Cross-linked Hyaluronic acid 2.3 % (23 mg/mL).

Indicated for correction of medium to deep lines. Indicated for perioral wrinkles, lip contour and increase lip volume. It can be used for all areas of the face.

More details

49,17 €

Volume discounts

Quantity Discount You Save
10 4,00 € Up to 40,00 €
20 6,00 € Up to 120,00 €

More info

SAYPHA FILLER (1x1ml) / EX PRINCESS FILLER (1x1ml) CROMA

IN 2019 CROMA PRINCESS BECOMES CROMA SAYPHA

Saypha

DESCRIPTION

FILLER UNIVERSAL TREATMENTS

Based on hyaluronic acid (HA) of non-animal origin, thus hypoallergenic.

SAYPHA Filler is a monophasic, reticulated gel implant, based on hyaluronic acid of non-animal origin.

Cross-linked hyaluronic acid, formulated to a concentration of 23 mg/ml in a physiologic buffer.

CE Marked Medical Device class III. SMART - a unique method of cross–linking created by CROMA.

INDICATION

It is a universal product and appropriate for different aesthetic treatments such as the correction of moderate facial wrinkles and lines as well as the enhancement of lip volume.

Treatment is surprisingly simple and results are convincing – a natural, youthful, radiant appearance.

COMPOSITION

Cross-linked HA 2.3 % (23 mg/mL)

Level of cross-linking 2/4

BDDE (9%)

PACKAGE

NEEDLES 27 G1/2
Box of 1 mL prefilled syringe

INJECTION

Medium to deep derm.

SAFETY

That means no allergy testing is required previously to the treatment. The products are manufactured in Austria with a unique technology according to highest safety standards. The gels are absolutely pure, controlled and extremely well tolerated in the body. The treatment's results are immediately visible and long–lasting but not permanent. 



Concentration HA

2.3 % (23 mg/mL)

Reticulating agent 

BDDE

Other ingredients 

Phosphate-buffer, NaCI

Dynamic viscosity (at shear rate 2 s-1) 

70.000 – 100.000 mPa.s

Needle

2 x 27G 1⁄2 thin-wall needles

Packaging

Box of 1 mL syringe

Injection area

Mid to deep dermis 

Indication

Viscoelastic solution for the correction of moderately deep facial wrinkles and to augment lip volume.

Estimated duration in the skin

Up to 9 months

AREA OF APPLICATIONS
cheeks
nasolabial folds
marionette lines
chin
facial depressions

SAYPHA CROMA

FACE INJECTION AREAS

SAYPHA®
Croma's range of hyaluronic acid fillers includes six products: SAYPHA® RICH, SAYPHA® FILLER (with / without lidocaine), SAYPHA® VOLUME (with / without lidocaine) and SAYPHA® VOLUME PLUS Lidocaine.
These products target the individual needs of patients:

SAYPHA® RICH (EC 0459)

regenerates the loss of hyaluronic acid due to aging, improves hydration, skin tone and elasticity and corrects fine lines. The product is injected into the superficial dermal layer.

SAYPHA® FILLER (CE 0459) and SAYPHA® FILLER Lidocaine (CE 0120)

corrects moderate to severe wrinkles and facial wrinkles and increases lip volume (only applicable for SAYPHA® FILLER Lidocaine). The product is injected into the intermediate to deep dermis.

SAYPHA® VOLUME (CE 0459) and SAYPHA® VOLUME Lidocaine (EC 0120)

have been developed to correct deeper wrinkles and wrinkles and to restore facial volume / reshape facial contours.

The product is injected into the deeper skin layer (deep dermis or hypodermis).

SAYPHA® VOLUME PLUS Lidocaine (EC 0120)

is used for facial tissue augmentation to correct lowering of the volume of the middle part of the face and to define the contours of the face as well as for reconstruction purposes, for example in the treatment of facial lipoatrophy.

The product is injected subcutaneously, locally or in the deep dermis. All products are made from non-animal hyaluronic acid and are manufactured to the highest standards of quality and safety.

CROMA

Founded in 1976, Croma-Pharma GmbH (Croma) is an Austrian family-owned company specializing in the industrial production of hyaluronic acid for the fields of aesthetic medicine, ophthalmology and orthopedics. Croma currently manages 12 international sales companies and distributes its products in more than 70 countries. In its global sales network, Croma focuses on its own brand products for minimally invasive cosmetic medicine.

In addition to a wide range of hyaluronic acid-based fillers from its own production site, Croma markets PDO tensor yarns, a Platelet Rich Plasma System (PRP) and customized skin care technology. within its core strategic markets.

Accessories

Customers who bought this product also bought: